×
Thursday, December 8, 2022

ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Veru Inc. Investors to Inquire About Securities Class Action Investigation - VERU

Last updated Wednesday, November 23, 2022 17:47 ET

Vancouver Canada · V6E 4A6, Canada, 11/23/2022 / SubmitMyPR /

New York, New York--(Newsfile Corp. - November 23, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Veru Inc. (NASDAQ: VERU) resulting from allegations that Veru may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Veru securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=9728 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

WHAT IS THIS ABOUT: On November 10, 2022, Veru issued a press release announcing that the U.S. Food and Drug Administration's ("FDA") Pulmonary-Allergy Drugs Advisory Committee (the "Committee") voted against granting emergency use authorization ("EUA") for sabizabulin, Veru's product for treatment of hospitalized moderate to severe COVID-19 patients who are at high risk for acute respiratory distress syndrome. Specifically, the Committee voted 8-5 that the known and potential benefits of sabizabulin do not outweigh the known and potential risks.

On this news, Veru's stock price plummeted by $8.04 per share, or over 53%, to close at $6.97 per share on November 10, 2022.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/145275

Original Source of the original story >> ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Veru Inc. Investors to Inquire About Securities Class Action Investigation - VERU


This content is published on behalf of the above source. Please contact them directly for any concern related to the above. 

This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.